Review: Berberine as a multi-target modulator of aging hallmarks
This review examines how berberine, a plant alkaloid, may influence several hallmarks of aging through molecular mechanisms; it also discusses translational potential, pharmacokinetic challenges and safety. [1]
Automatic summary · not editorially reviewed
The key findings
The abstract describes a review of molecular mechanisms by which berberine influences energy metabolism, mitochondrial homeostasis, proteostasis, chronic inflammation and cellular senescence. [1]
According to the abstract, berberine activates AMPK via mild mitochondrial complex I inhibition and stimulates autophagic flux and mitophagy. [1]
The abstract states that berberine acts as a senomorphic agent, attenuating the SASP without inducing widespread apoptosis, partly through modulation of p16 and cyclin expression. [1]
The source at a glance
- Study type / format
- Narrative review (abstract only)
- Population / context
- Not specified in the abstract; the review concerns molecular and cellular mechanisms, not a defined human or animal population.
- Summary based on
- Study abstract
- Original publication
- September 28, 2026
Berberine review scope: aging hallmarks and mechanisms
The abstract describes a review that critically examines molecular mechanisms by which berberine influences energy metabolism, mitochondrial homeostasis, proteostasis, chronic inflammation and cellular senescence. Berberine is described as a naturally occurring isoquinoline alkaloid found in medicinal plants such as Berberis species and Coptis chinensis, long used in traditional medicine. The review positions it as a pleiotropic modulator of multiple interconnected hallmarks of aging and a promising candidate for geroprotective interventions.
Supporting source [1]
AMPK, mitophagy and inflammation in the review
According to the abstract, berberine activates AMP-activated protein kinase (AMPK) via mild inhibition of mitochondrial complex I, restoring cellular energy balance and suppressing mTOR-dependent anabolic pathways. Enhanced AMPK signaling is said to stimulate autophagic flux and mitophagy, promoting clearance of damaged mitochondria and aggregated proteins. Berberine is also described as improving respiratory efficiency, limiting pathological excessive reactive oxygen species while preserving physiological redox signaling, and upregulating antioxidant defenses through Nrf2. Anti-inflammatory effects are attributed to inhibition of NF-κB nuclear translocation and reduced transcription of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β).
Supporting source [1]
Senomorphic action and open questions in the review
The abstract states that berberine acts as a senomorphic agent, attenuating the senescence-associated secretory phenotype (SASP) without inducing widespread apoptosis, partly through modulation of p16 and cyclin expression. The review integrates these molecular insights to position berberine as a multi-target geromodulator addressing deregulated nutrient sensing, mitochondrial dysfunction, impaired proteostasis, chronic inflammation and cellular senescence in a coordinated manner. Translational potential, pharmacokinetic challenges and safety considerations in the context of healthy aging are also discussed.
Supporting source [1]
How to interpret this
This explainer is based only on the abstract; the full text was not reviewed. The abstract describes a review of proposed molecular mechanisms, not a clinical trial, and reports no human lifespan or health outcomes. Translational potential, pharmacokinetic challenges and safety are mentioned but not detailed in the abstract.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Alanazi SM, Al-Kuraishy HM, Abdelaziz AM, Alasmari EM, Yousef FM, Mohamed AA, Salama MM, Batiha GE. · europepmc.org · September 28, 2026